SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) April 7, 1997
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On April 7, 1997, Biocontrol Technology, Inc.
(NASDAQ:BICO) announced that a joint venture agreement was signed
by American Superpower Group, Inc, of Great Neck, NY, USA and
Biocontrol on Friday, April 4, 1997.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits-Press Release
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: April 7, 1997
BICO
BIOCONTROL TECHNOLOGY, INC.
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Release: Immediate
For More Information, Call:
Investors Media
Diane McQuaide Susan
Taylor
Biocontrol Technology Biocontrol
Technology
1.412.429.0673 phone 1.412.279.9455
phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL SIGNS JOINT VENTURE AGREEMENT
Pittsburgh, PA - April 7, 1997 - Biocontrol Technology,
Inc. (Nasdaq:BICO) announced today that a joint venture agreement
was signed by American Superpower Group, Inc. (ASG) of Great
Neck, New York, USA and Biocontrol on Friday, April 4, 1997.
The joint venture corporation will be known as Superpower-
BICO (International) Group, Inc. (SBIG), and will initially be
owned seventy-five percent (75%) by ASG and twenty-five percent
(25%) by Biocontrol.
As Biocontrol reported in a March 26, 1997 release, the
joint venture corporation will purchase product from Biocontrol
at cost plus profit. Such product, which will be sold by the
corporation in the Peoples Republic of China, Hong Kong & Taiwan,
will consist of the BioLogic-HT System for HIV/AIDS and cancer
treatment, the Diasensor 1000 noninvasive glucose sensor for
diabetics, the PRP and BIO-SOK oil spill cleanup products and
theraPORT vascular access system.
Efforts to market these products in China have already
begun, and the joint venture has registered to participate in
Medical `97 in Shanghai, P.R. China, July 15-19, 1997. At the
international exposition of medical equipment and technology,
ASG's significant contacts in China will be used to begin sales
of the medical products, including the Diasensor 1000.
Also in projection of this marketing in China, Biocontrol
will order additional BioLogic-HT Systems and step up production
of its PRP and BIO-SOK products.
Biocontrol also stated that the FDA-approved in-home study
of the Diasensor 1000 is proceeding as planned.
Originally founded in 1939 in the Far East for construction,
shipbuilding, oil drilling and general business investment, ASG
was chartered in New York State in 1978 to pursue a broad range
of joint projects.
Biocontrol Technology, Inc. has its corporate offices in
Pittsburgh, Pennsylvania USA and is involved in the development
and manufacture of biomedical devices and environmental products.
